Institute of Pathology

The impact of the tumor microenvironment on the survival of penile cancer patients. (2024) Lohse S, Mink JN, Eckhart L, Hans MC, Jusufi L, Zwick A, Mohr T, et al. Journal article Reduction in Renal Heme Oxygenase-1 Is Associated with an Aggravation of Kidney Injury in Shiga Toxin-Induced Murine Hemolytic-Uremic Syndrome. (2024) Mestekemper AN, Pirschel W, Krieg N, Paulmann MK, Daniel C, Amann KU, Coldewey SM Journal article Protease-activated receptor 2 deficient mice develop less angiotensin II induced left ventricular hypertrophy but more cardiac fibrosis. (2024) Meyer zu Schwabedissen A, Vergarajauregui S, Bertog M, Amann KU, Engel F, Daniel C Journal article AI allows pre-screening of FGFR3 mutational status using routine histology slides of muscle-invasive bladder cancer. (2024) Bannier PA, Saillard C, Mann P, Touzot M, Maussion C, Matek C, Klümper N, et al. Journal article CD19-targeting CAR T-cell therapy in patients with diffuse systemic sclerosis: a case series (2024) Auth J, Müller F, Völkl S, Bayerl N, Distler JH, Tur C, Raimondo MG, et al. Journal article Blockade of the CD47/SIRPα checkpoint axis potentiates the macrophage-mediated antitumor efficacy of tafasitamab. (2024) Biedermann A, Patra-Kneuer M, Mougiakakos D, Büttner-Herold M, Mangelberger-Eberl D, Berges J, Kellner C, et al. Journal article Extra-abdominal and intra-abdominal FET::CREM fusion mesenchymal neoplasms: comparative clinicopathological study of 9 new cases further supporting a distinct potentially aggressive sarcoma and report of novel sites (2024) Agaimy A, Blakely M, Breimer GE, Hölsken A, Koppes SA, Meidenbauer N, Rijken JA, et al. Journal article Conventional (bone-type) giant cell tumor of the larynx: the first case with proven H3-3A: c.103G >T (p.Gly35Trp) mutation (2024) Laco J, Vosmikova H, Satankova J, Dedkova J, Mejzlik J, Chrobok V, Agaimy A Journal article Molekulare Testung bei mesenchymalen Neoplasien: Was, wann und wie testen? Eine Übersicht mit besonderem Fokus auf den Stellenwert der Next-Generation-Immunhistochemie als Alternative für molekulare Testung (2024) Agaimy A Journal article Impact of CCND1 amplification on the prognosis of hormone receptor–positive, HER2-negative breast cancer patients—correlation of clinical and pathological markers (2024) Hanf D, Fasching P, Gaß P, Beckmann M, Hack C, Heindl F, Häberle L, et al. Journal article